Skip to main content
My Podcast Gift (12.24.2021)
Merry Christmas and Happy Holidays from RheumNow. Dr. Jack Cush tells his podcast story - the genesis, keys to success and recommendations on how to get into podcasting - for teaching, practice, fun or influence. Be sure to register for RheumNow.Live 2022 - March 19 & 20, 2022 in Las Colinas, Texas.
Watch: Dual BAFF/APRIL Antagonist for SLE

https://t.co/ktAhM2C0i7

Dr. John Cush RheumNow

4 years 9 months ago
Watch: Dual BAFF/APRIL Antagonist for SLE https://t.co/ktAhM2C0i7
ICYMI: AstraZeneca announced that Saphnelo (anifrolumab - Type 1 IFN receptor MAb) was recommended for approval in the

Dr. John Cush RheumNow

4 years 9 months ago
ICYMI: AstraZeneca announced that Saphnelo (anifrolumab - Type 1 IFN receptor MAb) was recommended for approval in the EU by CHMP for the treatment of patients with systemic lupus erythematosus https://t.co/Aiem2P4Em0
RA Panel: Safety, Multimorbidities, Vaccination and the Weather

https://t.co/0N212LKSzK

Dr. John Cush RheumNow

4 years 9 months ago
RA Panel: Safety, Multimorbidities, Vaccination and the Weather https://t.co/0N212LKSzK
Watch: Steroids in RA Patients 65 and Older

https://t.co/5cHMfSRSAi

Dr. John Cush RheumNow

4 years 9 months ago
Watch: Steroids in RA Patients 65 and Older https://t.co/5cHMfSRSAi
Are you a zoomatologist or a doomsatologist? Zoom has replaced the meeting, the teleconference or the board meeting. If your old meetings were bad, then your replacement zoom meetings will also be bad, if not worse. Largely because you have failed to master the medium. Here are the rules of Zoom.
HCQ is one of the safest meds used in rheumatology, but new claims data suggests a small increase in the risk of malformations associated with first-trimester HCQ use. The March 2021 issue of the American Journal of Obstetrics and Gynecology studied the risk of major congenital malformations during the first trimester of pregnancy in women with rheumatic disease taking HCQ.
Voclosporin FDA Approved for Lupus Nephritis in Jan 2022 - have you used it yet?
On 1/22 the FDA approved voclosporin (

Dr. John Cush RheumNow

4 years 9 months ago
Voclosporin FDA Approved for Lupus Nephritis in Jan 2022 - have you used it yet? On 1/22 the FDA approved voclosporin (Lupkynis) for use in adults with active lupus nephritis (LN). https://t.co/vpEtzanOmp https://t.co/STbJY1N4zB
Drs. Len Calabrese, David Liew, Richard Conway and Sarah Mackie discuss GCA and PMR-related abstracts presented at the A

Dr. John Cush RheumNow

4 years 9 months ago
Drs. Len Calabrese, David Liew, Richard Conway and Sarah Mackie discuss GCA and PMR-related abstracts presented at the ACR21 annual meeting. https://t.co/3uqzWscABx https://t.co/BT0LZw7YWF
As many of you are aware, I have written and spoken on COVID-19 extensively over these past 20 months, and just last month wrote about the dangers of the delta variant. In July, things took an unexpected turn when I developed a breakthrough infection with the delta variant.
The 2021 Medscape Survey on Physician burnout ranks rheumatology second, just behind Critical Care medicine. The survey included over 12,000 physcians from 20 specialties. While 42% of MDs claimed to be burnt-out, Rheumatologists claimed this 50% of the time. The top 3 this year were Critical care (51%), Rheumatology (50%) and infectious disease (49%).
RT @EricTopol: We're now learning about the T-cell response to Omicron after an mRNA vaccine boosters. That's why these

Eric Topol EricTopol

4 years 9 months ago
We're now learning about the T-cell response to Omicron after an mRNA vaccine boosters. That's why these new findings in people with multiple sclerosis on immunosuppressive therapy are very encouraging https://t.co/Gzv9sQTsuA https://t.co/SoezeVWgR3
×